Position in NVCR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,108,631
+$173,597 QoQ
Shares Held
73,177
-14.7% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 217 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 29%
Shared 0%
None 70%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Focus Partners Wealth holds $359,236,206 across 39 Medical Devices names. NVCR ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,753,727 | $159,133,187 | |
| 2 | SYK |
Stryker Corp
|
184,736 | $58,162,282 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
813,268 | $52,057,284 | |
| 4 | MDT |
Medtronic plc
|
391,155 | $30,600,055 | |
| 5 | BSX |
Boston Scientific Corp
|
383,366 | $16,362,060 | |
| 6 | TXG |
10x Genomics, Inc.
|
214,296 | $8,216,108 | |
| 7 | ITGR |
Integer Holdings Corp
|
67,575 | $6,314,883 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
66,322 | $5,709,660 |
All Filings in NVCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,108,631 | 73,177 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $935,034 | 85,783 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,140,180 | 88,181 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,670,209 | 93,832 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,645,445 | 92,337 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $2,767,585 | 92,872 | Shares | Sole | 2025-05-20 | |
| 2024-09-30 | $1,492,602 | 95,496 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,625,876 | 94,914 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,458,044 | 93,285 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $805,697 | 53,965 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||